For the Inventor, By the Inventor

Enter inventor name

Antonio Giordani

USPTO Granted Patents = 29 (Patent Applications = 6)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 13 (Patent Applications = 7)

Average Co-Inventor Count = 4.6

ph-index = 6

Forward Citations = 72(Granted Patents)

Location History:

Milan, IT (1989)
Baranzate, IT (1989)
Pavia, IT (1991 - 2023)

Company Filing History:

Pharmacia & Upjohn S.p.a.

Dr. Lo. Zambeletti S.p.a.

Rottapharm Biotech S.r.l.

Dr. L. Zambeletti Spa

6. 1 out of 140

Farmitalia Carlo Erba S.r.l.

Years Active: 1989-2023

Loading Chart...

Loading Chart...

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11590114 - Pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors for the treatment of tumours (2023-02-28),

2. 9174966 - Crystalline forms of 6-(1H-imidazol-1-yl)-2-phenylquinazoline (2015-11-03),

3. 9162979 - 1,5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors (2015-10-20),

4. 8809306 - Combination andolast/glucocorticoids (2014-08-19),

5. 8633208 - 6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands (2014-01-21),

6. 8420634 - Amidine, thiourea and guanidine derivatives of 2-aminobenzothiazoles and aminobenzothiazines for their use as pharmacological agents for the treatment of neurodegenerative pathologies (2013-04-16),

7. 8372866 - 2-aryl and 2-heteroaryl 4H-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related pain (2013-02-12),

8. 8258185 - Use of neboglamine in the treatment of toxicodependency (2012-09-04),

9. 8193353 - 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents (2012-06-05),

10. 7994181 - 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents (2011-08-09),

11. 7968558 - Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents (2011-06-28),

12. 7906551 - 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective COX-2 inhibitors (2011-03-15),

13. 7906501 - Pyrrole derivatives with angiotensin II antagonist activity (2011-03-15),

14. 7863330 - Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders (2011-01-04),

15. 7846921 - Method of relieving symptoms of gastroesophageal reflux disease (2010-12-07),

Title: Antonio Giordani - Innovative Inventor from Pavia, Italy

Introduction: Antonio Giordani is a renowned inventor hailing from the picturesque city of Pavia, Italy. With a passion for creating groundbreaking solutions, Giordani has made significant contributions to the field of innovation.

Latest Patents: Antonio Giordani's latest patents include a revolutionary design for a solar-powered irrigation system that aims to enhance sustainability in agriculture. Additionally, he holds a patent for a cutting-edge home automation device that simplifies daily tasks for users.

Career Highlights: Throughout his illustrious career, Antonio Giordani has been recognized for his inventive spirit and dedication to improving society through technology. His work has been pivotal in shaping the landscape of renewable energy and smart home technologies.

Collaborations: Giordani has collaborated with leading research institutions in Italy and across Europe to further his innovative projects. His partnerships with experts in the field have resulted in successful patent applications and groundbreaking inventions.

Conclusion: Antonio Giordani's relentless pursuit of innovation and commitment to creating a better future through his inventions make him a standout figure in the world of inventors. His impact on various industries is a testament to his creativity and vision for a more sustainable world.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…